1 |
MARIAMPILLAI K, GRANGER B, AMELIN D,et al.Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies[J]. JAMA Neurol, 2018, 75(12): 1528-1537.
|
2 |
TARGOFF I N. Immune manifestations of inflammatory muscle disease[J]. Rheum Dis Clin North Am, 1994, 20(4): 857-880.
|
3 |
BETTERIDGE Z, MCHUGH N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis[J]. J Intern Med, 2016, 280(1): 8-23.
|
4 |
SATOH M, TANAKA S, CERIBELLI A, et al. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy[J]. Clin Rev Allergy Immunol, 2017,52(1): 1-19.
|
5 |
MERLO G, CLAPASSON A, COZZANI E, et al. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets[J]. Arch Dermatol Res, 2017, 309(2): 87-95.
|
6 |
SUGIE K, TONOMURA Y, UENO S. Characterization of dermatomyositis with coexistence of anti-jo-1 and anti-SRP antibodies[J]. Intern Med, 2012, 51(7): 799-802.
|
7 |
VINCZE M, MOLNÁR P A, TUMPEK J, et al. An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis[J]. Clin Rheumatol, 2010, 29(7): 811-814.
|
8 |
MELGUIZO MADRID E, FERNÁNDEZ RIEJOS P, TOYOS SÁENZ DE MIERA F J, et al. Coexistence of anti-Jo1 and anti-signal recognition particle antibodies in a polymyositis patient[J]. Reumatol Clin (Engl Ed), 2019, 15(6): e111-e113.
|
9 |
COBOS G A, FEMIA A, VLEUGELS R A. Dermatomyositis: an update on diagnosis and treatment[J].Am J Clin Dermatol,2020,21(3):339-353.
|
10 |
AGGARWAL R, CASSIDY E, FERTIG N, et al. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients[J]. Ann Rheum Dis, 2014, 73(1): 227-232.
|
11 |
VÁNCSA A, CSÍPO I, NÉMETH J, et al. Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients[J]. Rheumatol Int, 2009, 29(9): 989-994.
|
12 |
NISHIKAI M, REICHLIN M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system[J]. Arthritis Rheum, 1980, 23(8): 881-888.
|
13 |
CASCIOLA-ROSEN L, ANDRADE F, ULANET D, et al. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity[J]. J Exp Med, 1999, 190(6): 815-826.
|
14 |
HOWARD O M, DONG H F, YANG D, et al. Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells[J]. J Exp Med, 2002, 196(6): 781-791.
|
15 |
WALTER P, BLOBEL G. Purification of a membrane-associated protein complex required for protein translocation across the endoplasmic reticulum[J]. Proc Natl Acad Sci U S A, 1980, 77(12): 7112-7116.
|
16 |
REEVES W H, NIGAM S K, BLOBEL G. Human autoantibodies reactive with the signal-recognition particle[J]. Proc Natl Acad Sci U S A, 1986, 83(24): 9507-9511.
|
17 |
BERGUA C, CHIAVELLI H, ALLENBACH Y,et al. In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy[J]. Ann Rheum Dis,2019,78(1): 131-139.
|
18 |
ALLENBACH Y, AROUCHE-DELAPERCHE L, PREUSSE C, et al. Necrosis in anti-SRP+ and anti-HMGCR+myopathies: role of autoantibodies and complement[J]. Neurology, 2018, 90(6): e507-e517.
|
19 |
AROUCHE-DELAPERCHE L, ALLENBACH Y, AMELIN D, et al. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies[J]. Ann Neurol, 2017, 81(4): 538-548.
|
20 |
ARLET J B, DIMITRI D, PAGNOUX C, et al. Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP)[J]. Neuromuscul Disord, 2006, 16(5): 334-336.
|
21 |
WHELAN B R, ISENBERG D A. Poor response of anti-SRP-positive idiopathic immune myositis to B-cell depletion[J]. Rheumatology (Oxford),2009,48(5):594-595.
|
22 |
梁文芳,肖慧娟,高聪聪,等.皮肌炎合并间质性肺炎的危险因素及预后因素分析[J]. 郑州大学学报(医学版),2021,56(5):722-726.
|